Imunon, Inc. (IMNN) - Dilution Analysis

10-K filing | 3.9M shares outstanding

10-Q filing | 2.9M shares outstanding

8-K filing: Stock split | Outstanding: 2 → 2

8-K filing: Stock split 1-for-15 | Outstanding: 17,541,732 → 2

8-K filing: Imunon, Inc. registered an additional $4,500,000 of shares of its common stock pursuant to an At the Market Offering Agreement, bringing the aggregate shares registered to $10,000,000. Prior to this date, the Company has sold an aggregate of $1,815,267 shares of Common Stock through the Sales Agent under the Sales Agreement.

S-1 filing: This S-1 filing relates to the offer and resale of up to 22,027,780 shares of common stock by the selling securityholders.

8-K filing: Imunon, Inc. entered into a securities purchase agreement for a private placement involving the issuance and sale of common stock, pre-funded warrants, and warrants, resulting in gross proceeds of approximately $3.25 million. ($3.25M proceeds)

RW filing: The registrant has determined not to pursue the public offering and requests withdrawal of the registration statement.

S-1/A filing: IMUNON, INC. is offering up to 16,666,667 shares of common stock, common warrants to purchase up to 73,333,333 shares of common stock, and pre-funded warrants to purchase up to 16,666,667 shares of common stock on a best-efforts basis.

S-1/A filing: IMUNON, Inc. is offering up to 15,000,000 shares of common stock, common warrants to purchase up to 45,000,000 shares of common stock, and pre-funded warrants to purchase up to 15,000,000 shares of common stock, along with the underlying shares, on a reasonable best-efforts basis.

8-K filing: Imunon, Inc. issued 2,921,000 shares of common stock in exchange for warrants to purchase 5,000,000 shares.

10-Q filing | 14.6M shares outstanding

S-1 filing: IMUNON, INC. is offering up to 10,000,000 shares of common stock, warrants, and pre-funded warrants on a best-efforts basis, with the offering terminating on May 13, 2025, unless terminated earlier.

10-K filing | 14.6M shares outstanding

10-Q filing | 14.4M shares outstanding

S-1/A filing: This prospectus relates to the proposed resale from time to time, by the selling security holders identified in this prospectus, of up to 5,000,000 shares of the common stock which are issuable upon the exercise of certain outstanding warrants.

S-1 filing: This S-1 filing is for the resale of up to 5,000,000 shares of common stock issuable upon the exercise of outstanding warrants.

10-Q filing | 14.4M shares outstanding

8-K filing: Imunon, Inc. filed a prospectus supplement for the sale and issuance of 5,000,000 shares of common stock in a registered direct offering.

S-3 filing: Imunon, Inc. files an S-3 to offer common stock, preferred stock and debt securities up to an aggregate amount of $75,000,000.

10-Q filing | 9.4M shares outstanding

RW filing: The Registrant has determined not to pursue, at this time, the public offering to which the Registration Statement relates and is requesting withdrawal of the Registration Statement.

10-K filing | 9.0M shares outstanding

S-1/A filing: IMUNON, INC. is offering up to 14,035,087 shares of common stock, Series A warrants to purchase up to 14,035,087 shares of common stock, Series B warrants to purchase 14,035,087 shares of common stock, and pre-funded warrants to purchase up to 14,035,087 shares of common stock at an assumed combined public offering price of $0.57 per share.

S-1/A filing: IMUNON, INC. is offering up to 12,121,212 shares of common stock, common warrants, and pre-funded warrants on a best-efforts basis.

S-1 filing: IMUNON, INC. is offering common stock, common warrants, and pre-funded warrants on a reasonable best-efforts basis.

10-Q filing | 9.4M shares outstanding

10-Q filing | 9.1M shares outstanding

10-Q filing | 8.3M shares outstanding

10-K filing | 9.1M shares outstanding

10-Q filing | 7.1M shares outstanding

10-Q filing | 7.0M shares outstanding

10-Q filing | 7.1M shares outstanding

8-K filing: Celsion Corporation entered into a Securities Purchase Agreement to issue and sell 1,328,274 shares of common stock at $5.27 per share in a registered direct offering, for gross proceeds of approximately $7.0 million. ($7.0M proceeds)

10-K filing | 5.8M shares outstanding

8-K filing: Celsion Corporation redeemed all of its 50,000 outstanding shares of Series A Convertible Redeemable Preferred Stock and 50,000 Series B Convertible Redeemable Preferred Stock for cash at a price equal to 105% of the $300 stated value per share.

8-K filing: Stock split 1-for-15 | Outstanding: 86,557,736 → 112,500,000

8-K filing: Celsion Corporation completed offerings of 50,000 shares of Series A Preferred Stock and 50,000 shares of Series B Preferred Stock on January 13, 2022.

8-K filing: Celsion Corporation entered into a Securities Purchase Agreement to issue and sell 50,000 shares each of Series A and Series B Convertible Redeemable Preferred Stock in concurrent registered direct offerings, and intends to call a special meeting of stockholders to consider a reverse stock split ranging from 7-to-1 to 15-to-1. ($28.5M proceeds)

10-Q filing | 86.6M shares outstanding

10-Q filing | 86.6M shares outstanding

10-Q filing | 86.6M shares outstanding

8-K filing: Celsion Corporation entered into a Securities Purchase Agreement to issue and sell 11,538,462 shares of common stock at $1.30 per share in a registered direct offering for gross proceeds of approximately $15 million. ($15.0M proceeds)

S-3 filing: This is an S-3 filing for a shelf registration, allowing the company to offer shares of common stock, preferred stock, and debt securities, warrants, rights or units comprised of two or more of the foregoing securities in one or more offerings, for a total maximum offering price not to exceed $100,000,000.

10-K filing | 75.0M shares outstanding

8-K filing: Celsion Corporation entered into a Securities Purchase Agreement with institutional investors to issue and sell 25,925,925 shares of common stock at $1.35 per share in a registered direct offering, for gross proceeds of approximately $35 million. ($35.0M proceeds)

10-Q filing | 37.4M shares outstanding

S-3 filing: This S-3 filing relates to the resale of up to 247,524 shares of common stock by selling stockholders, issuable upon exercise of outstanding common stock purchase warrants.

8-K filing: Celsion Corporation entered into a Purchase Agreement with Lincoln Park Capital Fund, LLC, for the right to sell up to $26.0 million of shares of the Company's common stock. ($1.0M proceeds)

8-K filing: Celsion Corporation issued Horizon Technology Finance Corporation new warrants exercisable at a per share exercise price equal to $1.01 for a total of 247,525 shares of Celsion's common stock.

10-Q filing | 33.2M shares outstanding

S-3/A filing: This prospectus relates solely to the resale of up to 3,200,000 shares of our common stock issuable upon exercise of outstanding common stock purchase warrants.

S-3 filing: This prospectus relates solely to the resale of up to 3,200,000 shares of our common stock issuable upon exercise of outstanding common stock purchase warrants.

8-K filing: Celsion Corporation entered into an underwriting agreement with Oppenheimer & Co. Inc. for the issuance and sale of 2,666,667 shares of common stock at a public offering price of $3.75 per share. ($9.1M proceeds)

8-K filing: The company amended its bylaws regarding exclusive jurisdiction for litigation matters and reached a settlement agreement regarding a shareholder action, which includes repricing stock options and implementing certain corporate governance measures.

10-Q filing | 29.3M shares outstanding

10-K filing | 18.8M shares outstanding

8-K filing: Celsion Corporation issued new warrants to purchase up to 3,200,000 shares of common stock in exchange for original warrants, with a higher exercise price of $1.24 per share.

8-K filing: Celsion Corporation completed a registered direct offering of 4,571,428 shares of common stock at $1.05 per share, resulting in gross proceeds of approximately $4.8 million, and a concurrent private placement of warrants to purchase up to 2,971,428 shares of common stock. ($4.8M proceeds)